Abstract
This thesis addresses challenges in biomarker and test evaluation research, particularly focusing on non-invasive biomarkers for detecting outcomes in patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is a progressive disease characterized by fat accumulation in hepatocytes, and liver biopsy is the current standard for diagnosis, but non-invasive alternatives are sought.
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 8 Sept 2023 |
Print ISBNs | 9789464694543 |
Publication status | Published - 2023 |